And hopefully by the end of my administration businesses will look back and say, you know what, actually the guy was pretty good for business -- even if at any given point in the road they may be frustrated.
Critics say that incentives for these yearly discussions are excessive and will lead patients to scale back on end-of-life care, which may be what the Obama administration has in mind.